Related Experiment Video
Updated: Jul 20, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations
W L Atiga1, L Fananapazir, D McAreavey
1Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
Insights
Patients with hypertrophic cardiomyopathy (HCM) caused by beta-myosin heavy-chain (beta-MHC) gene mutations show abnormal heart repolarization. This labile repolarization, identified by QT variability analysis, may increase their risk of sudden cardiac death.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Hypertrophic cardiomyopathy (HCM) linked to genetic mutations increases sudden death risk.
- QT variability analysis is a tool for identifying high-risk patients with ventricular arrhythmias.
- Beta-myosin heavy-chain (beta-MHC) gene mutations are a known cause of HCM.
Purpose of the Study:
- To investigate if HCM patients with beta-MHC gene mutations exhibit labile ventricular repolarization.
- To assess the utility of beat-to-beat QT variability analysis in these patients.
- To correlate QT variability abnormalities with specific beta-MHC mutations.
Main Methods:
- QT variability index and heart rate-QT interval coherence were measured using Holter monitors.
- 36 patients with HCM due to beta-MHC mutations were studied.
- 26 age- and sex-matched healthy individuals served as controls.
Main Results:
- HCM patients exhibited significantly higher QT variability index compared to controls.
- Patients with the Arg(403)Gln beta-MHC mutation showed the most pronounced QT variability abnormalities.
- Lower heart rate-QT interval coherence was observed in HCM patients, particularly those with the Arg(403)Gln mutation.
Conclusions:
- HCM patients with beta-MHC gene mutations demonstrate labile repolarization, suggesting an elevated risk of sudden death.
- QT variability analysis can quantify repolarization abnormalities in HCM.
- Specific beta-MHC mutations, like Arg(403)Gln, are associated with more severe QT variability, indicating a poorer prognosis.
Background:
Certain genetic mutations associated with hypertrophic cardiomyopathy (HCM) carry an increased risk of sudden death. QT variability identifies patients at a high risk for sudden death from ventricular arrhythmias. We tested whether patients with HCM caused by beta-myosin heavy-chain (beta-MHC) gene mutations exhibit labile ventricular repolarization using beat-to-beat QT variability analysis.
Methods And Results:
We measured the QT variability index and heart rate-QT interval coherence from Holter monitor recordings in 36 patients with HCM caused by known beta-MHC gene mutations and in 26 age- and sex-matched controls. There were 7 distinct beta-MHC gene mutations in these 36 patients; 9 patients had HCM caused by the malignant Arg(403)Gln mutation and 8 patients had HCM caused by the more benign Leu(908)Val mutation. The QT variability index was higher in HCM patients than in controls (-1.24+/-0.17 versus -1. 58+/-0.38, P<0.01), and the greatest abnormality was detected in patients with the Arg(403)Gln mutation (-0.99+/-0.49 versus -1. 46+/-0.43 in controls, P<0.05). In keeping with this finding, coherence was lower for the entire HCM group than for controls (P<0. 001). Coherence was also significantly lower in patients with the Arg(403)Gln mutation compared with controls (P<0.05).
Conclusions:
These findings suggest that (1) patients with HCM caused by beta-MHC gene mutations exhibit labile repolarization quantified by QT variability analysis and, hence, may be more at risk for sudden death from ventricular arrhythmias, and (2) indices of QT variability may be particularly abnormal in patients with beta-MHC gene mutations that are associated with a poor prognosis.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy